The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman

The Prevalence and Impact of Evidence-Based Medications on Cardiovascular and Cerebrovascular Outcomes in Patients with Acute Coronary Syndrome Post-Revascularization in Oman

Objectives: International cardiovascular guidelines recommend prescribing a combination of five evidence-based medications (EBM) for acute coronary syndrome (ACS) patients post-revascularization. This study aims to assess the prevalence and impact of prescribing the full (five medications) versus pa...

Full description

Bibliographic Details
Main Authors: Dalia Ahmed Al-Hadithy, Juhaina Salim Al-Maqbali, Adil Al-Riyami, Mohammed Al Za’abi, Ibrahim Al-Zakwani
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Pharmacy
Subjects:
acute coronary syndrome
evidence-based medications
drug utilization
major adverse cardiovascular events
revascularization
Oman
Online Access:https://www.mdpi.com/2226-4787/11/3/79

Internet

https://www.mdpi.com/2226-4787/11/3/79

Similar Items